Page last updated: 2024-10-24

calmidazolium and Breast Neoplasms

calmidazolium has been researched along with Breast Neoplasms in 3 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
" Initial experiments investigated the effects of ICI 164384, a pure estrogen antagonist, on proliferation kinetics in asynchronous cultures of MCF-7 human breast cancer cells."3.67Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. ( Musgrove, EA; Sutherland, RL; Wakeling, AE, 1989)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strobl, JS1
Peterson, VA1
Woodfork, KA1
Newton, CJ1
Eycott, K1
Green, V1
Atkin, SL1
Musgrove, EA1
Wakeling, AE1
Sutherland, RL1

Other Studies

3 other studies available for calmidazolium and Breast Neoplasms

ArticleYear
A survey of human breast cancer sensitivity to growth inhibition by calmodulin antagonists in tissue culture.
    Biochemical pharmacology, 1994, Jun-15, Volume: 47, Issue:12

    Topics: Breast Neoplasms; Calmodulin; Culture Techniques; Drug Resistance; Humans; Imidazoles; Receptors, Es

1994
Response of estrogen receptor containing tumour cells to pure antiestrogens and the calmodulin inhibitor, calmidzolium chloride.
    The Journal of steroid biochemistry and molecular biology, 2000, Volume: 73, Issue:1-2

    Topics: Breast Neoplasms; Calmodulin; Cell Death; Dose-Response Relationship, Drug; Drug Synergism; Estradio

2000
Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
    Cancer research, 1989, May-01, Volume: 49, Issue:9

    Topics: Breast Neoplasms; Calmodulin; Cell Cycle; Clomiphene; DNA; Estradiol; Estrogen Antagonists; Female;

1989